BRPI0911978A2 - conjugados antitumorais de direcionamento duplo - Google Patents

conjugados antitumorais de direcionamento duplo

Info

Publication number
BRPI0911978A2
BRPI0911978A2 BRPI0911978A BRPI0911978A BRPI0911978A2 BR PI0911978 A2 BRPI0911978 A2 BR PI0911978A2 BR PI0911978 A BRPI0911978 A BR PI0911978A BR PI0911978 A BRPI0911978 A BR PI0911978A BR PI0911978 A2 BRPI0911978 A2 BR PI0911978A2
Authority
BR
Brazil
Prior art keywords
double
targeting antitumor
conjugates
antitumor conjugates
targeting
Prior art date
Application number
BRPI0911978A
Other languages
English (en)
Inventor
Dal Pozzo Alma
Esposito Emiliano
Ni Minghong
Penco Sergio
Pisano Claudio
Castorina Massimo
Vesci Loredana
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of BRPI0911978A2 publication Critical patent/BRPI0911978A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0911978A 2008-05-20 2009-05-11 conjugados antitumorais de direcionamento duplo BRPI0911978A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08156575 2008-05-20
PCT/EP2009/055653 WO2009141240A1 (en) 2008-05-20 2009-05-11 Novel dual targeting antitumoural conjugates

Publications (1)

Publication Number Publication Date
BRPI0911978A2 true BRPI0911978A2 (pt) 2019-09-24

Family

ID=39765065

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911978A BRPI0911978A2 (pt) 2008-05-20 2009-05-11 conjugados antitumorais de direcionamento duplo

Country Status (16)

Country Link
US (1) US20110160147A1 (pt)
EP (1) EP2285396A1 (pt)
JP (1) JP2011523415A (pt)
KR (1) KR20110022594A (pt)
CN (1) CN102036676A (pt)
AR (1) AR071840A1 (pt)
AU (1) AU2009249795A1 (pt)
BR (1) BRPI0911978A2 (pt)
CA (1) CA2724562A1 (pt)
EA (1) EA201071326A1 (pt)
IL (1) IL208920A0 (pt)
MX (1) MX2010012320A (pt)
NZ (1) NZ588948A (pt)
TW (1) TW201004647A (pt)
WO (1) WO2009141240A1 (pt)
ZA (1) ZA201009036B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7985401B2 (en) 2003-10-31 2011-07-26 The Regents Of The University Of California Peptides whose uptake by cells is controllable
US9682151B2 (en) 2009-07-15 2017-06-20 The Regents Of The University Of California Peptides whose uptake in cells is controllable
MX347298B (es) * 2010-12-29 2017-04-21 Arrowhead Res Corp Conjugados de suministro de polinucleotidos in vivo que tienen acoplamientos sensibles a enzima.
CN103874512B (zh) 2011-07-29 2016-11-16 艾维拉斯生物科学公司 选择性递送分子及使用方法
WO2014120837A2 (en) * 2013-01-29 2014-08-07 The Regents Of The University Of California Pretargeted activatable cell penetrating peptide with intracellulary releaseable prodrug
CN105102484B (zh) 2013-01-30 2020-03-10 艾维拉斯生物科学公司 选择性递送分子及使用方法
CN103333227B (zh) * 2013-06-07 2015-10-07 东南大学 转移肿瘤缺失蛋白小分子环肽抑制剂及其制备方法与应用
UA118113C2 (uk) * 2013-12-16 2018-11-26 Дженентек, Інк. Пептидоміметичні сполуки та їх кон'югати антитіла з лікарським засобом
WO2016008112A1 (en) 2014-07-16 2016-01-21 Medshine Discovery Inc. Linkers and application towards adc thereof
US10385380B2 (en) 2014-10-02 2019-08-20 The Regents Of The University Of California Personalized protease assay to measure protease activity in neoplasms
US10125124B2 (en) 2015-03-20 2018-11-13 Massachusetts Institute Of Technology Formation of macromolecules using iterative growth and related compounds
US10596259B2 (en) 2015-05-20 2020-03-24 The Regents Of The University Of California Tumor radiosensitization with monomethyl auristatin E (MMAE) and derivatives thereof
US10017577B2 (en) 2015-06-15 2018-07-10 Genentech, Inc. Antibodies and immunoconjugates
MX2021005134A (es) * 2018-11-05 2021-07-07 Bayer Pharma AG Nuevos conjugados citostaticos con ligandos de integrina.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01011502A (es) * 1999-05-14 2003-08-20 Boehringer Ingelheim Pharma Compuestos de tipo profarmaco anti-tumorigenos, activados por enzimas.
ITRM20040240A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori Camptotecine coniugate in posizione 7 con antagonisti delle integrine.
US8404650B2 (en) * 2005-10-28 2013-03-26 The Regents Of The University Of Colorado, A Body Corporate Methods of treating cancer with doxazolidine and prodrugs thereof

Also Published As

Publication number Publication date
US20110160147A1 (en) 2011-06-30
AU2009249795A1 (en) 2009-11-26
AR071840A1 (es) 2010-07-21
JP2011523415A (ja) 2011-08-11
EP2285396A1 (en) 2011-02-23
ZA201009036B (en) 2012-01-25
KR20110022594A (ko) 2011-03-07
MX2010012320A (es) 2010-12-01
IL208920A0 (en) 2011-01-31
EA201071326A1 (ru) 2011-06-30
CN102036676A (zh) 2011-04-27
TW201004647A (en) 2010-02-01
CA2724562A1 (en) 2009-11-26
WO2009141240A1 (en) 2009-11-26
NZ588948A (en) 2011-10-28

Similar Documents

Publication Publication Date Title
EP2480230A4 (en) DR5 Ligand-HEILMITTELKONJUGATE
DK2437790T3 (da) Konjugeringsfremgangsmåder
EP2417249A4 (en) DNA ZELLENKONJUGATE
IL211180B (en) Attached polyethylene glycol and docetaxel
BRPI0921327A2 (pt) Combinação de herbicida-protetor
BRPI0813707A2 (pt) Derivados de pirimidinil-piridazinona
BRPI0820112A2 (pt) Derivados de isoxazol-piridina
BRPI0809992A2 (pt) Derivados de pirrolopirimidina
BRPI0820113A2 (pt) Derivados de isoxazolo-piridazina
PT2180901E (pt) Purificação de conjugados utilizando hidroxiapatite
BRPI0915064A2 (pt) derivados de qunoxalinadiona
BRPI0812155A2 (pt) derivados de espiroindolinona
BRPI0817935A2 (pt) Derivados de biarila
BRPI0809660A2 (pt) Carrinho de criança
BRPI0809659A2 (pt) Carrinho de criança
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
BRPI0814236A2 (pt) Derivados de quinazolinamida
BRPI0820649A2 (pt) Derivados de isoxazalo-pirazina
BRPI0812518A2 (pt) Derivados de indazolamida
EP2206502A4 (en) POLYMER CONJUGATE OF A STEROIDS
BRPI0922652A2 (pt) Derivados de quinazolinamida
EP2259958A4 (en) LINKAGE
BRPI0913234A2 (pt) derivados de tiazolilpiperidina
BRPI0822525A2 (pt) gerar mapas de sites
BRPI0814718A2 (pt) Derivados de isoxazol-imidazol

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.